Q4 2025 Neogen Corp Earnings Call Transcript
Key Points
- Neogen Corp (NEOG) reported strong growth in pathogen detection products, particularly with the launch of new assays like the MDS quant Salmonella test and Listeria right now on the MDS platform.
- The USDA's increased focus on food safety, including a 200% increase in Listeria testing, aligns well with Neogen Corp (NEOG)'s product offerings, providing a regulatory tailwind.
- Neogen Corp (NEOG) completed the divestiture of its cleaners and disinfectants business, resulting in approximately $115 million in net proceeds, which will be used to pay down $100 million of debt.
- The company has successfully remediated two Sarbanes-Oxley material weaknesses, reflecting improvements in internal controls.
- Neogen Corp (NEOG) expects positive free cash flow in fiscal 2026 due to significantly lower capital expenditures, projected at approximately $50 million.
- Neogen Corp (NEOG) experienced a decline in core revenue by 290 basis points in the fourth quarter, with foreign currency and discontinued products being significant headwinds.
- The Animal Safety segment faced a core revenue decline of 6.7%, attributed to a cyclical trough and a 70-year low in cattle herd size.
- The company is dealing with inefficiencies in sample collection production, leading to elevated costs and manual labor requirements.
- Neogen Corp (NEOG) recorded a $598 million noncash goodwill impairment charge related to the 3M Food Safety division acquisition.
- The company anticipates a $10 million annualized tariff impact in fiscal 2026, reflecting ongoing global trade uncertainties.
Good morning, ladies and gentlemen. Welcome to Neogen Corporation fourth quarter FY 2025 earnings call. (Operator Instructions) This call is being recorded on Tuesday, July 29, 2025.
I would now like to turn the conference over to Bill Waelke. Please go ahead.
Thank you for joining us this morning for the discussion of the fourth quarter of our 2025 fiscal year. I'll briefly cover non-GAAP and forward-looking language before passing the call over to our CEO, John Adent, who will be followed by our CFO and COO, David Naemura. Before the market opened today, we published our fourth-quarter results as well as a presentation with both documents available in the Investor Relations section of our website.
On our call this morning, we will refer to certain non-GAAP financial measures that we believe are useful in evaluating our performance. Reconciliations of historical non-GAAP financial measures are included in our earnings release and the presentation, slide 2 of which provides a reminder that our
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
